BTX - BioTime EPS misses by $0.14 beats on revenue August, 08 2019 04:40 PM Brooklyn ImmunoTherapeutics Inc. BioTime (NYSEMKT:BTX): Q2 GAAP EPS of -$0.20 misses by $0.14.Revenue of $0.78M (-69.3% Y/Y) beats by $0.22M.Shares -1%.Press ReleaseMore news on: BioTime, Inc., Earnings news and commentary, Healthcare stocks news, ,